DB15895InvestigationalProtein Based Therapies
XAV-19 is an intravenous antibody-based treatment targeted towards SARS-CoV-2 and other coronaviruses . The therapy concept is based on COVID-19 convalescent plasma. However, rather than using human plasma, XAV-19 is... However, rather than using human plasma, XAV-19 is a heterologous swine glyco-humanized polyclonal antibody that targets the spike protein of SARS-CoV-2.
- Mechanism
- Curator reviewed
Pharmacologically active on Spike glycoprotein
- Code names
- XAV-19
Resolves to
Targets
What you can answer from here — as of July 08, 2026
Which drugs share a target with XAV-19, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account